Swiss skincare company Galderma reported a strong start to the year, with first-quarter sales rising 25.5% in constant-currency terms to $1.47 billion. The Zug-based firm was buoyed by robust demand in the United States, where sales jumped 41.5% year-on-year between January and March. Popular brands such as Cetaphil and Restylane contributed significantly to the growth, Continue Reading